Global extent of chloroquine-resistant Plasmodium vivax: a systematic review and meta-analysis

BACKGROUND: Chloroquine is the first-line treatment for Plasmodium vivax malaria in most endemic countries, but resistance is increasing. Monitoring of antimalarial efficacy is essential, but in P vivax infections the assessment of treatment efficacy is confounded by relapse from the dormant liver s...

Descripción completa

Detalles Bibliográficos
Autores principales: Price, Ric N, von Seidlein, Lorenz, Valecha, Neena, Nosten, Francois, Baird, J Kevin, White, Nicholas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2014
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178238/
https://www.ncbi.nlm.nih.gov/pubmed/25213732
http://dx.doi.org/10.1016/S1473-3099(14)70855-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4178238/
https://www.ncbi.nlm.nih.gov/pubmed/25213732
http://dx.doi.org/10.1016/S1473-3099(14)70855-2

Ejemplares similares